Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
Peng Men,1,2 Tianbi Liu,1,3 Suodi Zhai1,2 1Department of Pharmacy, Peking University Third Hospital, Beijing, People’s Republic of China; 2Institute for Drug Evaluation, Peking University Health Science Center, Beijing, People’s Republic of China; 3Department of Pharmacy Administ...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-08-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/empagliflozin-in-type-2-diabetes-mellitus-patients-with-high-cardiovas-peer-reviewed-article-DMSO |